Literature DB >> 10977794

Dialysate hyaluronan concentration predicts survival but not peritoneal sclerosis in continuous ambulatory peritoneal dialysis.

C C Szeto1, T Y Wong, K B Lai, C W Lam, K N Lai, P K Li.   

Abstract

Hyaluronan is an important component of extracellular matrix and plays a critical role in early phases of wound healing. Peritoneal mesothelium is a major site of hyaluronan production. Serum hyaluronan concentration has been shown to predict survival in maintenance hemodialysis patients. We hypothesize that mesothelial production of hyaluronan during the stable phase of continuous ambulatory peritoneal dialysis (CAPD) predicts the risk of peritoneal adhesion and mortality. We studied peritoneal dialysate effluent (PDE) hyaluronan levels from 116 stable CAPD patients. They were then followed-up for 3 years. During the follow-up period, there were 196 episodes of peritonitis in 78 patients. Tenckhoff catheter was removed in 31 episodes (15.8%). Tenckhoff catheter was reinserted successfully in 12 cases, and CAPD was resumed. Peritoneal adhesion developed in 16 cases. Three patients died before Tenckhoff catheter reinsertion was attempted. There was no difference in stable-phase PDE hyaluronan levels between patients who developed peritoneal adhesion and those who did not (159 +/- 63 versus 227 +/- 194 microgram/L, P = 0.27). Thirty-three patients died during the study period. Patients who died had significantly higher PDE hyaluronan concentration than survivors (272 +/- 194 versus 170 +/- 105 microgram/L, P < 0.01). Univariate analysis showed that increased PDE hyaluronan level was associated with a shorter patient survival (P < 0.001). There was no association between PDE hyaluronan level and serum albumin, protein nitrogen appearance, and percentage of lean body mass. Multivariate analysis confirmed that PDE hyaluronan level, serum albumin, and diabetic state were independent predictors of survival. We conclude that PDE hyaluronan level during stable phase of CAPD does not predict the risk of postperitonitis adhesion. However, it is a strong independent predictor of survival in CAPD patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10977794     DOI: 10.1053/ajkd.2000.16201

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  6 in total

Review 1.  Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions.

Authors:  Anneleen Pletinck; Raymond Vanholder; Nic Veys; Wim Van Biesen
Journal:  Nat Rev Nephrol       Date:  2012-07-10       Impact factor: 28.314

2.  Characterization of peritoneal dialysis effluent-derived cells: diagnosis of peritoneal integrity.

Authors:  Yo Higashi; Koji Abe; Tomoaki Kuzumoto; Takuya Hara; Keiichi Miyamoto; Tomohiro Murata; Eiji Ishikawa; Shinsuke Nomura; Takashi Horiuchi
Journal:  J Artif Organs       Date:  2012-12-30       Impact factor: 1.731

Review 3.  Encapsulating peritoneal sclerosis: the state of affairs.

Authors:  Mario R Korte; Denise E Sampimon; Michiel G H Betjes; Raymond T Krediet
Journal:  Nat Rev Nephrol       Date:  2011-08-02       Impact factor: 28.314

4.  Effluent free radicals are associated with residual renal function and predict technique failure in peritoneal dialysis patients.

Authors:  Hiroshi Morinaga; Hitoshi Sugiyama; Tatsuyuki Inoue; Keiichi Takiue; Yoko Kikumoto; Masashi Kitagawa; Shigeru Akagi; Kazushi Nakao; Yohei Maeshima; Ikuko Miyazaki; Masato Asanuma; Makoto Hiramatsu; Hirofumi Makino
Journal:  Perit Dial Int       Date:  2012-01-03       Impact factor: 1.756

Review 5.  Peritoneal changes in patients on long-term peritoneal dialysis.

Authors:  Raymond T Krediet; Dirk G Struijk
Journal:  Nat Rev Nephrol       Date:  2013-05-14       Impact factor: 28.314

Review 6.  Pathophysiology of the peritoneal membrane during peritoneal dialysis: the role of hyaluronan.

Authors:  Susan Yung; Tak Mao Chan
Journal:  J Biomed Biotechnol       Date:  2011-12-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.